DBV Technologies (DBVT) Retained Earnings (2014 - 2026)
DBV Technologies (DBVT) reported Retained Earnings of -$440.7 million for Q1 2026, down 42638.61% year-over-year from N/an in Q1 2025, and down 88240.0% on a QoQ basis from $500000.0 in Q4 2025.
DBV Technologies (DBVT) has 13 years of Retained Earnings data on file, last reported at -$440.7 million in Q1 2026.
- Quarterly Retained Earnings fell 42638.61% year-over-year to -$440.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$440.7 million (down 42638.61% YoY) and the FY2025 annual result came in at $500000.0, down 44.75% from the prior year.
- Retained Earnings slipped to -$440.7 million in Q1 2026 per DBVT's latest filing, from $500000.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $1.0 million in Q1 2025 and bottomed at -$440.7 million in Q1 2026.
- The 5-year median for Retained Earnings is $500000.0 (2025), against an average of -$139.5 million.
- The widest annual swing landed in 2022, when Retained Earnings slumped 69077.19%; it then surged 100.39% in 2025.
- Tracing DBVT's Retained Earnings over 5 years: stood at $781000.0 in 2022, then retreated by 4.99% to $742000.0 in 2023, then grew by 21.97% to $905000.0 in 2024, then tumbled by 44.75% to $500000.0 in 2025, then sank by 88240.0% to -$440.7 million in 2026.
- Per Business Quant, the three latest DBVT Retained Earnings figures stand at -$440.7 million (Q1 2026), $500000.0 (Q4 2025), and -$348.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -24.89 Mn |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | -440.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -440.70 Mn |
| Dec 31, 2025 | 500,000.00 |
| Sep 30, 2025 | -348.30 Mn |
| Jun 30, 2025 | -315.14 Mn |
| Mar 31, 2025 | 1.04 Mn |
| Dec 31, 2024 | 905,000.00 |
| Sep 30, 2024 | 709,000.00 |
| Jun 30, 2024 | -232.89 Mn |
| Mar 31, 2024 | -266.21 Mn |
| Dec 31, 2023 | 742,000.00 |
| Sep 30, 2023 | 761,000.00 |
| Jun 30, 2023 | 687,000.00 |
| Mar 31, 2023 | -280.14 Mn |
| Dec 31, 2022 | 781,000.00 |
| Sep 30, 2022 | -220.34 Mn |
| Jun 30, 2022 | 743,000.00 |
| Mar 31, 2022 | -275.22 Mn |
| Dec 31, 2021 | -258.53 Mn |
| Sep 30, 2021 | 474,000.00 |
| Jun 30, 2021 | 446,000.00 |
| Mar 31, 2021 | 399,000.00 |
| Dec 31, 2020 | 484,000.00 |
| Jun 30, 2020 | -612.43 Mn |
| Dec 31, 2019 | -448.31 Mn |
| Sep 30, 2019 | -457.99 Mn |
| Jun 30, 2019 | -463.73 Mn |
| Dec 31, 2018 | -290.99 Mn |
| Jun 30, 2018 | -315.87 Mn |
| Dec 31, 2017 | -154.94 Mn |
| Jun 30, 2017 | -159.04 Mn |
| Dec 31, 2016 | -55.03 Mn |
| Jun 30, 2016 | -76.15 Mn |
| Dec 31, 2015 | -43.38 Mn |
| Jun 30, 2015 | -53.34 Mn |
| Dec 31, 2014 | -32.92 Mn |